Clinical Trials

NOT_YET_RECRUITING
A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL
This is a Phase II single-center open label trial of the combination of ATRA and pembrolizumab treatment in patients with histologically proven, relap...
Conditions:
Relapsed Hodgkin Lymphoma Refractory Hodgkin Lymphoma Relapsed Non-Hodgkin Lymphoma Refractory Non-Hodgkin Lymphoma
1 more condition available...
Locations:
📍 Indianapolis, Indiana, United States
📍 Indianapolis, Indiana, United States
RECRUITING
Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer
This is a window-of-opportunity study which will evaluate the safety and feasibility of single-dose neoadjuvant Hepatic Artery (HA) chemotherapy (FUDR...
Conditions:
Pancreatic Ductal Adenocarcinoma
Locations:
📍 Durham, North Carolina, United States
RECRUITING
Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma
This study aimed to evaluate the efficacy of a novel regimen consisting of polatuzumab vedotin in combination with rituximab, gemcitabine, dexamethaso...
Conditions:
Diffuse Large B-cell Lymphoma
Locations:
📍 Chapel Hill, North Carolina, United States
RECRUITING
VSV-hIFNbeta-NIS in Treating Patients With Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
This phase I trial studies the best dose and side effects of recombinant vesicular stomatitis virus carrying the human NIS and IFN beta genes (VSV-hIF...
Conditions:
B-Cell Non-Hodgkin Lymphoma Histiocytic and Dendritic Cell Neoplasm Myelodysplastic Syndrome Previously Treated Myelodysplastic Syndrome
15 more conditions available...
Locations:
📍 Scottsdale, Arizona, United States
📍 Rochester, Minnesota, United States
NOT_YET_RECRUITING
Apricity CARE to Improve ICI Outcomes of Ethnic/Racial Minority NSCLC Patients
The purpose of this trial is to study the effectiveness of the AprictyRxTM care service to improve treatment outcomes of ethnic/racial minority N.S.C....
Conditions:
Non Small Cell Lung Cancer
Locations:
📍 New York, New York, United States
📍 New York, New York, United States
📍 New York, New York, United States
📍 New York, New York, United States
RECRUITING
Trial of Ulixertinib in Combination With Hydroxychloroquine in Patients With Advanced Gastrointestinal (GI) Malignancies
This is an open-label, prospective phase two basket trial assessing the efficacy of ulixertinib in combination with hydroxychloroquine in patients wit...
Conditions:
Tumor, Solid Gastrointestinal Cancer
Locations:
📍 Tucson, Arizona, United States
📍 San Francisco, California, United States
📍 Fairway, Kansas, United States
📍 Ann Arbor, Michigan, United States
5 more locations available...
NOT_YET_RECRUITING
Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction
The purpose of the study is to test how successful the retrieval rate of the new HydroMARK Plus Breast Biopsy Site Marker in comparison to HydroMARK.
Conditions:
Breast Neoplasm
Locations:
📍 Birmingham, Alabama, United States
RECRUITING
Positron Emission Tomography (PET) Imaging of Thrombosis
The purpose of the study is to evaluate a new radiotracer called 64Cu-FBP8 for PET-MR imaging of thrombosis. The tracer has the potential of detecting...
Conditions:
Atrial Fibrillation COVID-19 Cancer Thrombosis
Locations:
📍 Boston, Massachusetts, United States
RECRUITING
Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor
This study is a patient registry of people with Desmoplastic Small Round Cell Tumor (DSRCT). A patient registry is a collection of health information ...
Conditions:
Desmoplastic Small Round Cell Tumor
Locations:
📍 New York, New York, United States
RECRUITING
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
This is a Phase II study of allogeneic hematopoietic stem cell transplant (HCT) using a myeloablative preparative regimen (of either total body irradi...
Conditions:
Acute Leukemia Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Lymphoma
24 more conditions available...
Locations:
📍 Minneapolis, Minnesota, United States
RECRUITING
A Study of the Use of Fat Flap Reconstruction to Reduce Neck Injury After Cancer Treatment
The purpose of this study is to find out whether the fat ALT flap procedure is a safe and practical option for reducing neck morbidity in HNSCC patien...
Conditions:
Head and Neck Squamous Cell Carcinoma
Locations:
📍 New York, New York, United States
RECRUITING
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer
This is an open label, multicenter, single arm phase II study to evaluate the efficacy and safety of ribociclib and ET in patients with locoregional r...
Conditions:
Locoregional Recurrence Hormone Receptor-positive Breast Cancer HER2-negative Breast Cancer
Locations:
📍 Birmingham, Alabama, United States
📍 Phoenix, Arizona, United States
📍 Orlando, Florida, United States
📍 Chicago, Illinois, United States
13 more locations available...
RECRUITING
Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
This phase I trial tests the side effects and best dose of total marrow lymphoid irradiation along with chemotherapy, with fludarabine and melphalan, ...
Conditions:
Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Myelodysplastic Syndrome
Locations:
📍 Duarte, California, United States
RECRUITING
A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1)
This study is researching an investigational drug, called BNT116, in combination with cemiplimab. BNT116 and cemiplimab will each be called a "study d...
Conditions:
Advanced Non-Small Cell Lung Cancer
Locations:
📍 Los Angeles, California, United States
📍 Orange, California, United States
📍 Santa Monica, California, United States
📍 Louisville, Kentucky, United States
51 more locations available...
RECRUITING
Phase II Randomized-registry Embedded Study of Lymphoscintigraphy for Oropharyngeal Neoplasms to Enable Risk-adapted Nodal Guidance for Robotic Surgery and/or Radiotherapy (LONE-RANGR2)
To test a new radiation treatment design based on where your cancer is located. Most participants with oropharyngeal cancer are treated with radiation...
Conditions:
Oropharyngeal Neoplasms Robotic Surgery and/or Radiotherapy Lymphoscintigraphy
Locations:
📍 Houston, Texas, United States

Total Trials: 181 - 195 of 6772